Great Point Partners’s Ocular Therapeutix OCUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,728,723
Closed -$15.7M 39
2024
Q1
$15.7M Buy
1,728,723
+1,028,723
+147% +$9.36M 2.45% 19
2023
Q4
$3.12M Buy
+700,000
New +$3.12M 0.53% 29
2021
Q3
Sell
-919,887
Closed -$13M 40
2021
Q2
$13M Sell
919,887
-87,125
-9% -$1.24M 2.74% 15
2021
Q1
$16.5M Buy
1,007,012
+150,850
+18% +$2.48M 3.42% 15
2020
Q4
$17.7M Buy
+856,162
New +$17.7M 2.88% 14